GNPX (Genprex, Inc. Common Stock) Stock Analysis - SEC Filings

Genprex, Inc. Common Stock (GNPX) is a publicly traded Healthcare sector company. As of May 20, 2026, GNPX trades at $0.79 with a market cap of $8.39M and a P/E ratio of -0.04. GNPX moved -1.47% today. Year to date, GNPX is -56.12%; over the trailing twelve months it is -94.52%. Its 52-week range spans $0.74 to $198.50. Rallies surfaces GNPX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find GNPX SEC filings?

Rallies organizes GNPX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

GNPX Key Metrics

Key financial metrics for GNPX
MetricValue
Price$0.79
Market Cap$8.39M
P/E Ratio-0.04
EPS$-17.40
Dividend Yield0.00%
52-Week High$198.50
52-Week Low$0.74
Volume211.51K
Avg Volume0
Revenue (TTM)$0
Net Income$-16.23M
Gross Margin0.00%

Latest GNPX News

Recent GNPX Insider Trades

  • LONGNECKER BRENT M sold 8 (~$9.84) on Apr 14, 2026.
  • LONGNECKER BRENT M sold 10 (~$12.3) on Apr 14, 2026.
  • Varner John Rodney bought 19.00K (~$20.05K) on Apr 21, 2023.

GNPX Analyst Consensus

GNPX analyst coverage data. Average price target: $0.00.

Common questions about GNPX

Where can I find GNPX SEC filings?
Rallies organizes GNPX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show GNPX 10-K and 10-Q filings?
Rallies organizes GNPX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is GNPX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GNPX. It does not provide personalized investment advice.
GNPX

GNPX